Search result for Moderna Inc
- Japan’s state-run centers to give COVID-19 vaccines under ages 18 - 64.
- The centers in Tokyo and Osaka were set up last month by the Defense Ministry.
- The ministry last week expanded the scope to accept people from ...
- JAL began COVID-19 vaccination for its employees.
- The airlines decided to begin administering shots at Tokyo's Haneda airport.
- JAL aims to inoculate about 36,000 group employees.
- JR East, Itochu Corp., univ...
- Japan govt. approves Pfizer’s COVID-19 vaccines for 12-15 year old.
- The age group will be able to receive shots free of charge.
- Only around 6% of the country's population of 126 million has been given at least o...
- Japan to discuss approval for Moderna, AstraZeneca COVID-19 vaccine.
- The formal approval could be expected to come on Friday.
- The same vaccines are used overseas for people aged 18 or older.
- Prime Minister Yosh...
- Japan govt. to set aside $4.7 billion for FY 2021 in reserve funds.
- The funds will be earmarked to purchase more COVID-19 vaccines.
- Pfizer is expected to supply 50 million doses from July through September.
• The US Food and Drug Administration (FDA) on Friday granted clearance to Moderna to speed up output of its coronavirus vaccine by allowing it fill a single with nearly 15 doses
• Moderna said the vaccine developed by it now can be supplied in vials conta...
- Japan govt. to secure 20,000 freezers for hospital storage of COVID-19 vaccines.
- The govt. will sign contracts with four freezer makers.
- Japan govt. has secured 310 million vaccine doses from Pfizer Inc., Moderna Inc., an...
- Japan to collect data of people infected with COVID-19 even after vaccination.
- The health ministry will prepare a system to gather vaccination records of all infected people.
- It will then evaluate the effectiveness of the...
- 20 million doses of COVID-19 vaccines to be supplied by Moderna to South Korea.
- President of S. Korean and Moderna CEO held a video conference to confirm the deal.
- An official deal is likely to be signed within the end of...
• This recommendation comes at a time when distribution of COVID-19 vaccine developed by Moderna Inc. has started in the country
• By voting 13 to 1, the U.S. CDC Advisory Committee on Immunization Practices recommended 30 million frontline essential worke...
- COVID-19 vaccine hopes lead Tokyo stocks end higher on Tuesday.
- The 225-issue Nikkei Stock Average ended up at 353.92 points.
- The Topix index of all First Section issues on the TSE finished at 13.46 points.
- Tokyo stocks ended on a higher note on Tuesday.
- Nikkei ended highest with the 26,000 mark for the first time.
- The 225-issue Nikkei Stock Average ended up at 107.69 points.
- Stock issues gained in air transp...
- Moderna Inc. said that the company is planning to provide 80 million doses of its experimental corona virus vaccine to the European Union
- The company has completed the talks with the European Commission over a potential agreement
- Potential COVID-19 vaccine supply deal helps Tokyo stocks gain on Thursday.
- 225-issue Nikkei Stock Average gained by 428.38 points.
- Topix index was up by 17.56 points.
- Tokyo Electron stocks rose by 930 yen or ...
• US has already made deals for vaccine procurement with leading researchers of covid19 vaccines
• Trump stated that the US may look at sharing the vaccines with the world
The US has made deals with all ...
• The study samples of various vaccine candidates shall be carried out through the fall
• Moderna Inc. initiates the study for its vaccine studies
Moderna Inc. u...
- South Korean stock market closed above 2,200 level
- The same was credited due to hopes for the COVID-19 vaccine and economic recovery.
- KOSPI rose by 18.27 points.
- Trading volume was reported as high about 811 m...
- The European stock market rebounded on Wednesday.
- The share market index gained mostly due to pharmaceutical company’s boost in vaccine making.
- The pan-European STOXX 600 rose by 0.9%.
- U.S. biotech firm ...